MR
Muhammed Rafeek Thokkan
About Muhammed Rafeek Thokkan
Muhammed Rafeek Thokkan has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Rimal Ventures Llp and Rimal House (Opc) Private Limited. Formerly with 1 company, such as Sufoof Al Rimal Trading Llp. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Rimal Ventures Llp
AAX-2421
|
Designated Partner | 02 Jun 2021 | 2021 | Active |
Rimal House (Opc) Private Limited
U47590KL2026OPC099731
|
Director | 01 Jan 2026 | 2026 | Active |
Imtibish Health Care Private Limited
U85100KL2015PTC038145
|
Director | 18 Mar 2023 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Sufoof Al Rimal Trading Llp
AAH-5667
|
Designated Partner | 18 Jan 2024 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muhammed Rafeek Thokkan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muhammed Rafeek Thokkan
Muhammed Rafeek Thokkan has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 3 companies, including Rimal Ventures Llp and Rimal House (Opc) Private Limited. Formerly with 1 company, such as Sufoof Al Rimal Trading Llp. Engaged in General Business, Healthcare. Contributes to corporate operations.
Muhammed Rafeek Thokkan is associated with 3 companies as Designated Partner and Director.
Muhammed Rafeek Thokkan has expertise in General Business, Healthcare.
Muhammed Rafeek Thokkan has 5 years in corporate governance.